How Coronvirus Could Knock Off All the Good Work of Global Fund Partnership

Global Fund Partnership has saved nearly 38 million lives suffering or at risk of fatality from AIDS, TB and Malaria. However, due to the knock-on effects of the global pandemic, COVID-19, the efforts seem endangered at the moment.

A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. Due to the restricted flow of cash and limited human resources, the number of cases of deaths and infections from TB, AIDS and Malaria could skyrocket significantly in the next 12 months.

At places where Global Fund invests, the deaths caused by AIDS, TB and malaria each year have been reduced by nearly 50% since the peak of the epidemics.

Recommended: CTL NL81 Chromebooks Now Fill Technology Gap For Remote Workforce And…

Pre-COVID Effectiveness: 6 Million Lives Saved in 2019

The Global Fund partnership has saved 38 million lives since 2002, including 6 million in 2019 alone. This represents a 20 percent increase in the number of lives saved compared to the previous year – remarkable progress resulting from increased efficiencies in service delivery, success in finding and treating more people with lifesaving medicine, cost savings on health products, and improved collaboration across the Global Fund partnership.

Read Also: Microsoft Azure Spring Cloud: Features, Applications, And Cloud Computing Insights

However, the Results Report 2020 shows that much of that progress could now be lost due to the knock-on effects of COVID-19. Deaths and infections from HIV, TB and malaria could skyrocket in the next 12 months, the report warns.

Peter Sands, Executive Director of the Global Fund says –

“This year’s Results Report demonstrates how a united world, led by strong commitments by communities, can work together to drive diseases into retreat. We’ve made extraordinary progress, but COVID-19 now threatens to reverse the gains we have all worked so hard to achieve. We must not let that happen. We must unite to fight.”

Key Stats on HIV, AIDS, and Malaria during the COVID-19 Crisis

Key results achieved in 2019 in countries where the Global Fund invests:

• 20.1 million people received antiretroviral therapy for HIV;
• 718,000 HIV-positive mothers received medicine to keep them alive and prevent transmitting HIV to their babies;
• 5.7 million people tested and treated for TB;
• 160 million mosquito nets were distributed to protect nearly 320 million people from malaria for three years.

Achievements in the 2020 Results Report are a result of efforts by a wide array of actors comprising the Global Fund partnership, including implementer governments, multilateral agencies, bilateral partners, civil society groups, people affected by the diseases, and the private sector.

How Epidemics and Infections Affect Genders

The Global Fund made strong progress on several fronts in 2019. While girls are still disproportionately affected by HIV compared to their male peers, infection rates among adolescent girls and young women have dropped by 51% since 2010 in 13 priority countries in sub-Saharan Africa where the Global Fund invests.

The Global Fund also supported the purchase of 3.7 million self-testing kits; access to varied testing measures is fundamental to ending HIV as a public health threat.

Read More: OPTAGE and NanoLock to Enable Nationwide IoT Security in Japan

Fight Against TB during the COVID-19 Could take Massive Hit

A strategic initiative by the Global Fund, the Stop TB Partnership and WHO that focuses on 13 countries with the highest TB burden has accelerated progress in finding “missing” people with TB – people who go undiagnosed, untreated and unreported, and could die or continue to spread the disease to others without treatment. The gap between TB notifications and TB incidence in the 13 focus countries fell from 49% in 2014 to 33% in 2018.

Cost of Malarial Treatment at an Unprecedented Low

To protect people from malaria, the Global Fund worked with partners to reduce the cost of an insecticide-treated mosquito net to less than US$2 and the cost of antimalarial treatment dropped to US$0.58 in 2019 – savings that helped purchase more than 14 million extranets and treat more than 24 million additional people for malaria.

Those gains are now threatened by COVID-19. The report shows that the volume of HIV testing has dropped by 50% in some places and new TB case notifications have dropped by up to 75%, which could lead to a rise in new infections as people unaware of their status continue to transmit the diseases to others. Many countries have been forced to delay mosquito net distribution campaigns, leaving people vulnerable to malaria – most of them children – unprotected.

The Global Fund has responded swiftly to support countries to address these challenges.

How Global Fund Partnership Plans to Topple the COVID-19 Challenges

Since March 2020, the Global Fund has approved approximately US$700 million to 103 countries and 11 multi-country programs to fight COVID-19. The immediate action plan includes:

• through increased testing and tracing and protection for front-line health workers;
• adapt existing HIV, TB and malaria programs to protect progress; and
• reinforce systems for health so they don’t collapse and they are prepared to roll out COVID-19 treatments and vaccines once available.

“This is an inflection point,” said Sands. “We can surrender the gains we have made against HIV, TB and malaria, and allow our progress towards the Sustainable Development Goals to be sharply reversed. Or we can act with speed and scale, investing far greater resources than have yet been committed, to counter both the direct impact of COVID-19 and to mitigate the knock-on consequences for HIV, TB and malaria.”

SOURCE: The Global Fund to Fight AIDS, Tuberculosis and Malaria